30 Years working to identify, prevent and treat HIV/AIDS
June 5 marks the 30th year that U.S. public health agencies have been engaged in the war against HIV/AIDS, and GRA university partner Emory University has been a world leader in the fight. From inventing some of the most successful HIV/AIDS drugs, to developing and testing promising vaccines, conducting clinical trials, leading behavioral and prevention research and treating thousands of patients, Emory has played a key role.
GRA has invested significantly in winning the battle against this killer of more than 30 million worldwide through recruiting several of the most prominent AIDS researchers; by helping to develop the Emory Vaccine Center, the Emory Center for AIDS Research and the University of Georgia Center for Drug Discovery; by providing sophisticated research tools; and by fostering the growth of GeoVax, a Georgia company in Phase II clinical trials for a promising HIV/AIDS vaccine.
The war is far from over, but progress toward victory is being made, in no small part through the efforts of Georgia’s research universities.
Entry filed under: Commentary.